Drug Trial Radar · NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
268
Planned (sponsor's estimate)
Start
Mar 5, 2024
Primary completion
Feb 17, 2027
Study completion Jul 23, 2027
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Jan 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate medical problems. An endoscopy will be used to check the bowel for inflammation. The participants will be treated with TAK-279 for 52 weeks (1 year). During the study, participants will visit their study clinic 15 times.
Conditions
- Crohn's Disease
Interventions
TAK-279Drug
TAK-279 capsules.
PlaceboDrug
TAK-279 placebo-matching capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Endoscopic Response Based on Simple Endoscopic Score for Crohn's Disease (SES-CD) at Week 12Time frame: Week 12
Locations
201 sites in 25 countries. Site status is shown where the registry gives one.
United Medical Doctors
Murrieta, California · Recruiting
UCI Health
Orange, California · Recruiting
West Central Gastroenterology, LLP, d/b/a/ Gastro Florida
Clearwater, Florida · Recruiting
Auzmer Research
Lakeland, Florida · Recruiting
Wellness Clinical Research
Miami Lakes, Florida · Recruiting
GI PROS, Inc.
Naples, Florida · Recruiting
AdventHealth (Florida Hospital) Medical Group
Orlando, Florida · Not yet recruiting
USF Health Morsani Center for Advanced Healthcare
Tampa, Florida · Recruiting
Emory University Hospital, The Emory Clinic
Atlanta, Georgia · Recruiting
Atlanta Center For Gastroenterology, P.C.
Decatur, Georgia · Recruiting
The University of Iowa Hospitals & Clinics
Iowa City, Iowa · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
University Of Louisville
Louisville, Kentucky · Recruiting
Woodholme Gastroenterology Associates
Glen Burnie, Maryland · Recruiting
BVL Clinical Research
Liberty, Missouri · Recruiting
Las Vegas Medical Research
Las Vegas, Nevada · Recruiting
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH)
New York, New York · Recruiting
Rochester Clinical Research, Inc
Rochester, New York · Not yet recruiting
Great Lakes Gastroenterology Research, LLC
Mentor, Ohio · Recruiting
Hightower Clinical - SSM Health
Oklahoma City, Oklahoma · Completed
University Gastroenterology Providence
Providence, Rhode Island · Recruiting
Gastroenterology Associates, PA
Greenville, South Carolina · Recruiting
Novel Research, LLC
Bellaire, Texas · Recruiting
TDDC - Baylor University Medical Center Gaston Ave
Dallas, Texas · Completed
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance
Fort Worth, Texas · Completed
One of a Kind Clinical research Center TX LLC
Kingwood, Texas · Recruiting
TDDC dba Alliance Research
Mansfield, Texas · Completed
Southern Star Research Institute, LLC
San Antonio, Texas · Recruiting
Tyler Research Institute, LLC
Tyler, Texas · Recruiting
University of Washington Medical Center
Seattle, Washington · Recruiting
Northern Hospital Epping
Epping, Australia · Recruiting
Sir Charles Gairdner Hospital (SCGH) - Comprehensive Cancer Centre
Nedlands, Australia · Recruiting
Concord Repatriation General Hospital
Concord, New South Wales, Australia · Recruiting
Mater Cancer Care Centre-Mater Health Services
South Brisbane, Queensland, Australia · Recruiting
Flinders Medical Centre
Bedford Park, South Australia, Australia · Recruiting
The Queen Elizabeth Hospital
Woodville, South Australia, Australia · Recruiting
Western Health/Footscray Hospital
Footscray, Victoria, Australia · Recruiting
Harry Perkins Medical Research Institute Fiona Stanley Hospital
Murdoch, Western Australia, Australia · Recruiting
Royal Perth Hospital
Perth, Western Australia, Australia · Recruiting
CHU Saint-Pierre - Porte de Hal
Brussels, Belgium · Recruiting
Showing 40 of 201 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.